"Assistant Professor or Associate Professor or Professor, Early Drug Development"

The Stanford Cancer Institute (SCI) at the Stanford University School of Medicine seeks applicants to join our Early Drug Development (EDD) Program as an Assistant Professor or Associate Professor or Professor in the University Medical Line (UML). The successful candidate should be a fellowship-trained specialist in medical oncology, with a focus on early-phase clinical trials. Additionally, she or he should have a demonstrated track record or significant potential in obtaining research funding, along with a history of publishing in leading scientific or medical journals.

• The major criteria for appointment for faculty in the University Medical Line shall be excellence in the overall mix of clinical care, clinical teaching, scholarly activity that advances clinical medicine, and institutional service appropriate to the programmatic need the individual is expected to fulfill.

Faculty rank will be determined by the qualifications and experience of the successful candidate. The appointment will be in the Department of Medicine (Medical Oncology) and Stanford Cancer Institute.

The SCI leads an Early Drug Development (EDD) Program focused on Phase I clinical trials in oncology. These are typically studies where first in-human novel cancer therapeutics clinical trials are developed for our patients, incorporating biomarkers in their clinical design. Increasingly, these Phase I studies serve an important role in the oncology drug development ecosystem where not only toxicity, but efficacy data are acquired with the goal of improving the standard of care for oncology patients.

This position is open to candidates trained in developing and conducting early phase innovative clinical/translational trials with targeted agents and immunotherapeutics. The successful candidate will be expected to develop a clinical/translational research, teach graduate students, postdoctoral fellows and clinical fellows, and participate in the Oncology clinics. The SCI and the Division of Oncology benefits from an outstanding scientific and clinical environment, including active collaboration with the basic science departments and other Stanford Institutes. Eligible candidates must have an MD or MD/PhD and be board-certified in medical oncology.

The successful candidate will have experience working with a broad spectrum of investigators and, preferably, a dedicated interest in a particular disease area and/or focus on a therapeutic pathway, or experience with genomics and other biomarkers. Participation in relevant clinical and basic science conferences is also expected.

The mission of the Stanford Cancer Institute (SCI) is to leverage the broad and unique strengths of Stanford University in the sciences, in clinical care, and in translation to improve the diagnosis, treatment, and outcomes of cancer patients; to understand cancer etiologies among diverse populations; and to decrease cancer incidence. The SCI offers unique opportunities for the successful candidate to be integral to its mission and to join a faculty highly engaged in improving cancer research and patient care.

Applications will be reviewed immediately and accepted until the position is filled.

Candidates should submit the following materials: CV, cover letter outlining the applicant’s background and broad vision, a 2-page research interest statement, and a list of 3 references via the application link.

The expected base pay range for this position is:

Department of Medicine, Division of Oncology

Assistant Professor: $275,000 - $289,000

Associate Professor: $301,000 - $361,000

Professor: $380,000 - $447,000

This pay range reflects base pay, which is based on faculty rank and years in rank. It does not include all components of the School of Medicine’s faculty compensation program or pay from participation in departmental incentive compensation programs.

For questions regarding this position, please contact Mihaela Bozdog at mihaelab@stanford.edu